Safiglipron
Efficacy and Safety of HRS-7535 Tablets in Obese Subjects .
Shandong Suncadia Medicine Co · Phase 2 · Completed · Enrollment 235
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Group A | Obesity or overweight | n/r | n/r | n/r | n/r |
| Group B | Obesity or overweight | n/r | n/r | n/r | n/r |
| Group C | Obesity or overweight | n/r | n/r | n/r | n/r |
| Group D | Obesity or overweight | n/r | n/r | n/r | n/r |
| Group E | Obesity or overweight | n/r | n/r | n/r | n/r |